Wednesday, February 10, 2010, 6:50am EST - Canadian Markets open in 2 hours and 40 minutes.
To create a watchlist or portfolio of shares, Sign-in or Register

DepoMed Inc. (DEPO)

 On Feb 9: 2.90 USD   0.00 (0.00%)  
MORE ON DEPO
Quotes
HereSummary
Charts
News & Info
Company
Analyst Coverage
Ownership
Financials
Depomed, Inc. (NGM:DEPO) Delayed quote dataEdit
Last Trade: 2.90 USD
Trade Time: Feb 9
Change: 0.00 (0.00%)
Prev Close: 2.90
Open: N/A
Bid: 1.78 x 500
Ask: N/A
1y Target Est: 7.83
Day's Range: N/A - N/A
52wk Range: 1.66 - 6.40
Volume: 0
Avg Vol (3m): 284,597
Market Cap: 150.83M
P/E (ttm): N/A
EPS (ttm): -0.58
Div & Yield: N/A (N/A%)
DepoMed Inc. (DEPO)
1d  5d  3m  6m  1y  2y  5y  max 
 Add DEPO to Portfolio   Download Data

HEADLINES
• Depomed to Present at the 12th Annual BIO CEO & Investor Conference
Business Wire (Tue, Feb 2)
• Depomed Announces Allowance of U.S. Patent Covering Gastric Retentive Gabapentin Dosage Forms
Business Wire (Mon, Feb 1)
• Depomed Announces Receipt of $500,000 Milestone Payment from Covidien for the Development of a Second Formulation
Business Wire (Thu, Jan 21)
• DEPOMED INC Files SEC form 8-K, Other Events
EDGAR Online (Wed, Jan 20)
• UPDATE - Depomed to conduct another trial for hot flashes drug
at Reuters (Tue, Jan 19)
• Depomed Comments on FDA Guidance and Plans for One Additional Phase 3 Clinical Trial Evaluating Non-Hormonal Therapy for Menopausal Hot Flashes
Business Wire (Tue, Jan 19)
• 5 Cold Stocks Heating Up
at Motley Fool (Fri, Jan 15)
• DEPOMED INC Files SEC form 8-K, Change in Directors or Principal Officers
EDGAR Online (Fri, Jan 8)
• Neutral on Santarus
Zacks.com (Wed, Jan 6)
• Zacks #5 Rank Additions for Wednesday
Zacks.com (Wed, Jan 6)
• Huge Leaps for Small-Cap Pharma Plays
Indie Research (Tue, Dec 15)
• Prospecting for Stocks: DepoMed
at Motley Fool (Tue, Dec 8)
More Headlines for DEPO...
ANALYST
EPS Est (next year) (Dec-09) : -0.49
EPS Est (in 2 years) (Dec-10) : -0.47
Avg Rec (current)*: 1.8
PEG Ratio: N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion - Estimates

BUSINESS SUMMARY
Depomed, Inc., a specialty pharmaceutical company, develops and commercializes pharmaceutical products based on its proprietary oral drug delivery technologies in the United States.

Full Company Profile

Add to My Portfolio Add to Portfolio    Email to a Friend Email to a Friend
Get Summary for Another Symbol:
Symbol Lookup
• Latest News • Canadian Indices